DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination.

IF 3 4区 医学 Q2 GENETICS & HEREDITY
Epigenomics Pub Date : 2024-04-01 Epub Date: 2024-03-14 DOI:10.2217/epi-2023-0343
Meiqi Yang, Mei Wang, Xiaoyu Zhao, Feifei Xu, Shuang Liang, Yifan Wang, Nanxi Wang, Muhammed Lamin Sambou, Yue Jiang, Juncheng Dai
{"title":"DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination.","authors":"Meiqi Yang, Mei Wang, Xiaoyu Zhao, Feifei Xu, Shuang Liang, Yifan Wang, Nanxi Wang, Muhammed Lamin Sambou, Yue Jiang, Juncheng Dai","doi":"10.2217/epi-2023-0343","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To elucidate the epigenetic consequences of DNA methylation in healthspan termination (HST), considering the current limited understanding. <b>Materials & methods:</b> Genetically predicted DNA methylation models were established (n = 2478). These models were applied to genome-wide association study data on HST. Then, a poly-methylation risk score (PMRS) was established in 241,008 individuals from the UK Biobank. <b>Results:</b> Of the 63,046 CpGs from the prediction models, 13 novel CpGs were associated with HST. Furthermore, people with high PMRSs showed higher HST risk (hazard ratio: 1.18; 95% CI: 1.13-1.25). <b>Conclusion:</b> The study indicates that DNA methylation may influence HST by regulating the expression of genes (e.g., <i>PRMT6</i>, <i>CTSK</i>). PMRSs have a promising application in discriminating subpopulations to facilitate early prevention.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"461-472"},"PeriodicalIF":3.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/epi-2023-0343","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To elucidate the epigenetic consequences of DNA methylation in healthspan termination (HST), considering the current limited understanding. Materials & methods: Genetically predicted DNA methylation models were established (n = 2478). These models were applied to genome-wide association study data on HST. Then, a poly-methylation risk score (PMRS) was established in 241,008 individuals from the UK Biobank. Results: Of the 63,046 CpGs from the prediction models, 13 novel CpGs were associated with HST. Furthermore, people with high PMRSs showed higher HST risk (hazard ratio: 1.18; 95% CI: 1.13-1.25). Conclusion: The study indicates that DNA methylation may influence HST by regulating the expression of genes (e.g., PRMT6, CTSK). PMRSs have a promising application in discriminating subpopulations to facilitate early prevention.

DNA 甲基化标记鉴定和多甲基化风险评分在预测健康寿命终止中的作用。
目的:考虑到目前对 DNA 甲基化在健康终结(HST)中的表观遗传学影响的了解有限,旨在阐明其在健康终结中的影响。材料与方法建立遗传预测 DNA 甲基化模型(n = 2478)。这些模型被应用于有关 HST 的全基因组关联研究数据。然后,在英国生物库的 241 008 个个体中建立了多甲基化风险评分(PMRS)。结果显示在预测模型得出的 63046 个 CpGs 中,有 13 个新的 CpGs 与 HST 相关。此外,PMRS 较高的人显示出更高的 HST 风险(危险比:1.18;95% CI:1.13-1.25)。结论研究表明,DNA甲基化可能会通过调节基因(如 PRMT6、CTSK)的表达来影响 HST。PMRS 在区分亚群以促进早期预防方面具有广阔的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epigenomics
Epigenomics GENETICS & HEREDITY-
CiteScore
5.80
自引率
2.60%
发文量
95
审稿时长
>12 weeks
期刊介绍: Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community. Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信